AnaptysBio
$14.959876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$14.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.35 (+2.40%) Today
$0.00 (0.00%) As of 4:00 PM EST after-hours
Why Robinhood?
You can buy or sell AnaptysBio and other stocks, options, ETFs, and crypto commission-free!
About ANAB
AnaptysBio, Inc. Common Stock, also called AnaptysBio, is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Read More Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
CEO
Employees
78
Headquarters
San Diego, California
Founded
2005
Market Cap
423.28M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
646.12K
High Today
$15.37
Low Today
$14.16
Open Price
$14.17
Volume
830.59K
52 Week High
$83.10
52 Week Low
$10.00
Collections
Analyst Ratings
11%
of 9 ratings
Buy
11%
Hold
78%
Sell
11%
ANAB Earnings
-$1.15
-$0.77
-$0.38
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Expected Mar 10, Pre-Market
People Also Bought
CymaBay Therapeutics
5,112
$1.66
+0.61%Wave Life Sciences
3,838
$8.44
+7.52%Stealth BioTherapeutics
4,205
$1.80
-1.64%Spectrum Pharmaceuticals
4,395
$2.85
+18.75%Intelsat
11,519
$3.80
-6.40%NIO
125,857
$4.17
+0.72%Aurora Cannabis
672,917
$1.38
-4.83%Viking Therapeutics
39,935
$6.00
+0.67%Hexo
165,821
$1.16
-1.69%ABIOMED
3,530
$150.26
-2.41%Inovio
74,186
$4.24
-2.75%Cyclerion Therapeutics
1,821